L3VLUP
ProSign in

BHC in the 13F filings

Bausch Health Cos Inc · CUSIP 071734107

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Pharmaceutical preparations
Quarter
Q3 2026 · early filersQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
Quarter end
30 Jun 2025
the date the book describes
Filed
18 Aug 2025
latest of these filings; the earliest 13 Aug 2025
Managers listing it
5
at least, of 95 tracked, among listed positions
Comparable managers
95
filed both Q1 2025 and Q2 2025; 5 listed it in both
Shares listed
42,732,688
combined, among listed positions
Reported value
$285m
combined, at the quarter end

Among the 95 comparable managers: 0 buyers (opened or added shares) and 2 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -110,851.

Managers listing BHC in Q2 2025

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q1 2025, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

5 of 5 holders

ActionFiling
Carl C. Icahn34,721,118$231m2.93%Held014 Aug 2025 (the filing on sec.gov)
Hudson Bay Capital Management LP5,000,000$33m0.11%Held018 Aug 2025 (the filing on sec.gov)
Oaktree Capital Management LP1,270,000$8.5m0.15%Held013 Aug 2025 (the filing on sec.gov)
GAMCO Investors Inc997,007$6.6m0.07%Trimmed-46,43413 Aug 2025 (the filing on sec.gov)
Bridgewater Associates LP744,563$5.0munder 0.1%Trimmed-64,41713 Aug 2025 (the filing on sec.gov)

Largest increases and reductions, by shares

Q1 2025 to Q2 2025, among managers that listed it in both quarters or opened it.

Increases

No increase among listed positions.

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (0)

No new position among listed positions.

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
6 in Q3 2024 to 4 in Q2 2026

Tracked managers listing it, at least.

05101520192020202120222023202420252026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
BHC by quarter
QuarterHoldersReported valueBuyersSellers
Q2 20182$29mn.a.n.a.
Q3 201812$1.0bnn.a.n.a.
Q4 201814$718mn.a.n.a.
Q1 201913$1.1bnn.a.n.a.
Q2 201914$1.2bnn.a.n.a.
Q3 201910$982mn.a.n.a.
Q4 201910$1.5bnn.a.n.a.
Q1 202011$806mn.a.n.a.
Q2 20209$840mn.a.n.a.
Q3 202010$664mn.a.n.a.
Q4 202011$1.0bnn.a.n.a.
Q1 202112$2.3bnn.a.n.a.
Q2 202114$2.2bnn.a.n.a.
Q3 202110$2.0bnn.a.n.a.
Q4 20219$1.8bnn.a.n.a.
Q1 202213$1.5bnn.a.n.a.
Q2 20228$539mn.a.n.a.
Q3 202210$350mn.a.n.a.
Q4 20229$325mn.a.n.a.
Q1 20235$387mn.a.n.a.
Q2 20236$409mn.a.n.a.
Q3 20239$429mn.a.n.a.
Q4 20236$403m13
Q1 20249$594m33
Q2 20248$380m34
Q3 20246$331m14
Q4 20246$341m31
Q1 20255$277m22
Q2 20255$285m02
Q3 20254$47m12
Q4 20256$68m254
Q1 20265$61m819
Q2 20264$55m1211

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

BHC and LLY →BHC and JNJ →BHC and VRTX →Choose a stock to compare with BHC →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own BHC, latest filings →Back to the 13F Explorer →